Print Friendly, PDF & Email

Johnson & Bell Shareholder, Stacey A. Cischke, recently presented to the medical staff at a healthcare system on identifying vulnerabilities that present with patients at risk for VTE or already on anticoagulants.  She outlined strategies to mitigate potential vulnerabilities when caring for patients receiving anticoagulation therapy.  Lastly, she discussed the critical impact of timely and accurate documentation in successfully defending anticoagulation cases. If the medical staff at your healthcare facility could benefit from this presentation, please contact Ms. Cischke via email or phone.

Related

Cischke, Connery Secure Defense Verdict in Dispute Seeking $4M in Damages

Cischke, Jasinski Secure Defense Verdict in Dispute Seeking $3.6M in Damages